Ravid M, Brosh D, Ravid-Safran D, Levy Z, Rachmani R
Department of Medicine, Tel-Aviv University and Meir Hospital, Kfar-Sava, Israel.
Arch Intern Med. 1998 May 11;158(9):998-1004. doi: 10.1001/archinte.158.9.998.
The control of hyperglycemia is of major importance in the treatment of patients with type 1 diabetes mellitus. However, there is no consensus about the required degree of metabolic control in patients with type 2 diabetes mellitus and about the role of hyperglycemia in diabetic nephropathy and in the development of atherosclerosis in relation to other risk factors.
A prospective, long-term follow-up study was conducted on 574 patients, aged 40 to 60 years, with recent onset of type 2 diabetes mellitus. Patients were initially normotensive and had normal renal function and a normal urinary albumin excretion rate (<30 mg/24 h). The patients were followed up for 2 to 9 years (mean +/- SD, 7.8 +/- 0.9 years). Levels of hemoglobin A1c and plasma lipids, mean blood pressure, and body mass index (calculated as the weight in kilograms divided by the square of the height in meters) were determined periodically. Cigarette smoking and socioeconomic status were recorded. Renal status was evaluated by the logarithm of the final urinary albumin excretion rate and by the decline in reciprocal creatinine values. Definite clinical events including death, nonfatal myocardial infarction, angina pectoris, congestive heart failure, and peripheral vascular disease were recorded.
At the end of the study the urinary albumin excretion rate remained normal (<30 mg/24 h) in 373 patients (65%), 111 (19%) had microalbuminuria (30-300 mg/24 h), and 90 (16%) had overt albuminuria (>300 mg/24 h). Logistic regression models demonstrated that the correlation between hemoglobin A1c levels and the risk of albuminuria is exponential. Multiple logistic regression analysis indicated that levels of total cholesterol, mean blood pressure, and hemoglobin A1c were the main factors associated with the decrease in renal function and with the increase in albuminuria. The combination of values higher than the 50th percentile of all 3 factors defined a high-risk patient population. These high-risk patients had an odds ratio of 43 (95% confidence interval, 25-106) for microalbuminuria and 15 (95% confidence interval, 9-25) for clinical events related to arteriosclerosis compared with the rest of the group. Low levels of high-density lipoprotein, body mass index, cigarette smoking, low socioeconomic status, and male sex were all significantly associated with diabetic nephropathy, as well as with the manifestations of arteriosclerosis.
The combination of blood pressure values in the high-normal range with moderately elevated levels of total cholesterol and hemoglobin A1c defines a high-risk group for the progression to diabetic nephropathy and for clinical events related to arteriosclerotic cardiovascular disease.
高血糖的控制在1型糖尿病患者的治疗中至关重要。然而,对于2型糖尿病患者所需的代谢控制程度,以及高血糖在糖尿病肾病和动脉粥样硬化发生发展中相对于其他危险因素的作用,尚无共识。
对574例年龄在40至60岁、近期诊断为2型糖尿病的患者进行了一项前瞻性长期随访研究。患者最初血压正常,肾功能正常,尿白蛋白排泄率正常(<30mg/24h)。对患者进行了2至9年的随访(平均±标准差,7.8±0.9年)。定期测定糖化血红蛋白和血脂水平、平均血压及体重指数(计算方法为体重千克数除以身高米数的平方)。记录吸烟情况和社会经济状况。通过最终尿白蛋白排泄率的对数及肌酐倒数的下降情况评估肾脏状况。记录明确的临床事件,包括死亡、非致命性心肌梗死、心绞痛、充血性心力衰竭和外周血管疾病。
研究结束时,373例患者(65%)的尿白蛋白排泄率仍正常(<30mg/24h),111例(19%)有微量白蛋白尿(30 - 300mg/24h),90例(16%)有显性白蛋白尿(>300mg/24h)。逻辑回归模型表明,糖化血红蛋白水平与白蛋白尿风险之间的相关性呈指数关系。多元逻辑回归分析表明,总胆固醇水平、平均血压和糖化血红蛋白是与肾功能下降及白蛋白尿增加相关的主要因素。所有这3个因素高于第50百分位数的组合定义了一个高危患者群体。与组内其他患者相比,这些高危患者发生微量白蛋白尿的比值比为43(95%置信区间,25 - 106),与动脉硬化相关临床事件的比值比为15(95%置信区间,9 - 25)。高密度脂蛋白水平低、体重指数、吸烟、社会经济地位低及男性性别均与糖尿病肾病以及动脉硬化表现显著相关。
血压值处于高正常范围、总胆固醇水平适度升高以及糖化血红蛋白水平的组合定义了一个进展为糖尿病肾病及发生与动脉粥样硬化性心血管疾病相关临床事件的高危组。